OXURION
LIVE

Serial Number

79253776

Owner

Oxurion

Attorney

Martin W. Schiffmiller

Filing Date

Dec 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

OXURION Trademark

Serial Number: 79253776 • Registration: 5929399

OXURION is a trademark filed by Oxurion on December 18, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Oxurion

Gaston Geenslaan 1

Entity Type: 32

Trademark Details

Filing Date

December 18, 2018

Registration Date

December 10, 2019

Published for Opposition

September 24, 2019

Goods & Services

Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals

Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services

Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials, all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosing, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 10, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 23, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 23, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 10, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Oct 5, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 16, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 16, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 16, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 16, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2019 REAP
REFUSAL PROCESSED BY IB
Apr 12, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 27, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 16, 2019 MAFR
ASSIGNED TO EXAMINER
Mar 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2019 REPR